Key terms
About NAUT
Nautilus Biotechnology, Inc. is a life sciences company, which engages in the development of a proteomics platform for analyzing and quantifying the human proteome. Its products include Proteome Analysis System, Reagent Kits, and Software and Analysis. The company was founded by Sujal Patel and Parag Mallick in 2016 and is headquartered in Seattle, WA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest NAUT news
Mar 01
5:10am ET
Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), Tenet Healthcare (THC) and Nautilus Biotechnolgy (NAUT)
Feb 29
8:20am ET
Nautilus Biotechnology assumed with an Equal Weight at Morgan Stanley
Feb 28
4:30pm ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Feb 28
8:03am ET
Nautilus Biotechnology reports Q4 EPS (14c), consensus (14c)
Feb 28
7:36am ET
Nautilus Biotechnology files $300M mixed securities shelf
Feb 15
7:47am ET
SkyWater Technology signs production agreement with Nautilus Biotechnology
No recent press releases are available for NAUT
NAUT Financials
Key terms
Ad Feedback
NAUT Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
NAUT Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
